After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
"It's very, very clear that physician spending is not the problem in healthcare." -- Jen Brull, MD, president of the American ...
With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous ...
Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being “extremely effective” ...